Target intelligence / Profile preview

SH2 domain-containing protein 1A (SH2D1A)

Target
SH2D1A
Molecular classification
SH2 domain adaptor protein, signaling adaptor protein, other
01

Overview

SH2 domain-containing protein 1A (abbreviated SH2D1A; also known as SLAM-associated protein, SAP) is a cytoplasmic adaptor protein containing an SH2 domain, mainly expressed in lymphocytes[1][2][4]. It plays a critical role in the immune system by regulating signal transduction from signaling lymphocytic activation molecule (SLAM) family receptors and controlling lymphocyte activation, particularly T, B, and natural killer (NK) cells[2][4]. SH2D1A is essential for normal immune cell development and the induction of apoptosis in lymphocytes when they are no longer needed[2][4]. Mutations in the SH2D1A gene are the cause of X-linked lymphoproliferative disease (XLP or Duncan disease), resulting in an abnormal or absent protein that leads to severe immunodeficiency, heightened susceptibility to Epstein-Barr virus infection, and a strong predisposition to lymphoma and other immune dysregulation conditions[1][2][4][7]. SH2D1A works as a key modulator or inhibitor of SLAM family receptor signaling, and its absence disrupts the regulation of cytotoxic lymphocytes and NKT cell development[1][2][4][7].

Other names
DSHPSAPSLAM-associated proteinXLPMTCP1XLPDEBVSDuncan disease SH2-proteinsignaling lymphocyte activation molecule-associated proteinT cell signal transduction molecule SAPLYPIMD5SH2 domain protein 1ASH2D1A
02

Biological functions

Immune responseSignal transductionLymphocyte activationRegulation of apoptosisNatural killer T cell development
03

Disease associations

Cancer (lymphoma)Infection (Epstein-Barr virus susceptibility)Immunodeficiency (X-linked lymphoproliferative syndrome)Other
04

Safety considerations

Immunodeficiency riskextreme infection susceptibility (notably to Epstein-Barr virus)predisposition to lymphoproliferative diseases (e.g., lymphoma)

Beyond the preview

Go deeper on SH2 domain-containing protein 1A (SH2D1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SH2 domain-containing protein 1A (SH2D1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call